These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1408666)

  • 41. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
    Serradeil-Le Gal C
    Adv Exp Med Biol; 1998; 449():427-38. PubMed ID: 10026834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the understanding of water metabolism in heart failure.
    Schrier RW; Martin PY
    Adv Exp Med Biol; 1998; 449():415-26. PubMed ID: 10026833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Stassen FL; Heckman G; Schmidt D; Nambi P; Aiyar N; Landvatter S; Crooke ST
    Mol Pharmacol; 1987 Mar; 31(3):267-72. PubMed ID: 2951585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney.
    Gerstberger R; Fahrenholz F
    Eur J Pharmacol; 1989 Aug; 167(1):105-16. PubMed ID: 2528467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension.
    Szczepanska-Sadowska E; Stepniakowski K; Skelton MM; Cowley AW
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1217-25. PubMed ID: 7977848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential modulation of the baroreceptor reflex by brain and plasma vasopressin.
    Unger T; Rohmeiss P; Demmert G; Ganten D; Lang RE; Luft FC
    Hypertension; 1986 Jun; 8(6 Pt 2):II157-62. PubMed ID: 2941369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasopressin-induced calcium signaling in cultured cortical neurons.
    Son MC; Brinton RD
    Brain Res; 1998 May; 793(1-2):244-54. PubMed ID: 9630655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of arginine vasopressin and V1 receptor antagonist on brain water in cat.
    Rosenberg GA; Estrada E; Kyner WT
    Neurosci Lett; 1988 Dec; 95(1-3):241-5. PubMed ID: 3226612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
    Saad WA; Camargo LA; Antunes-Rodrigues J; Saad WA; Guarda IF; Guarda RS
    Regul Pept; 2005 Dec; 132(1-3):53-8. PubMed ID: 16198010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.
    Manning M; Stoev S; Kolodziejczyk A; Klis WA; Kruszynski M; Misicka A; Olma A; Wo NC; Sawyer WH
    J Med Chem; 1990 Nov; 33(11):3079-86. PubMed ID: 2231609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Opposite actions of different doses of arginine-vasotocin and 1-deamino-arginine-vasotocin on sodium ion transport in skin of the frog Rana temporaria].
    Bogolepova AE
    Zh Evol Biokhim Fiziol; 2011; 47(1):49-53. PubMed ID: 21469341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular physiology of water balance.
    Knepper MA; Kwon TH; Nielsen S
    N Engl J Med; 2015 Apr; 372(14):1349-58. PubMed ID: 25830425
    [No Abstract]   [Full Text] [Related]  

  • 55. Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist.
    Phillips PA; Abrahams JM; Kelly J; Paxinos G; Grzonka Z; Mendelsohn FA; Johnston CI
    Neuroscience; 1988 Dec; 27(3):749-61. PubMed ID: 3252172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the vasopressin-enhancing effect on memory retrieval and relearning by a vasopressin V1 receptor antagonist in mice.
    Alescio-Lautier B; Rao H; Paban V; Devigne C; Soumireu-Mourat B
    Eur J Pharmacol; 1995 Dec; 294(2-3):763-70. PubMed ID: 8750743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyaluronate-hydrolases system and hydroosmotic effect of vasopressin].
    Ivanova LN; Melidi NN
    Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):847-56. PubMed ID: 10512005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
    Pierson PM; Guibbolini ME; Lahlou B
    J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Through V2, not V1 receptor relating to endogenous opiate peptides, arginine vasopressin in periaqueductal gray regulates antinociception in the rat.
    Yang J; Chen JM; Liu WY; Song CY; Lin BC
    Regul Pept; 2006 Dec; 137(3):156-61. PubMed ID: 17011056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.